查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1615994

医疗三录仪市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032

Medical Tricorder Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球医用三录仪市场估值为37 亿美元，预计2024 年至2032 年复合年增长率为6.1%。 。糖尿病、心血管问题和呼吸系统疾病等慢性疾病的激增正在推动医疗三录仪市场的发展。影响因素包括人口老化、久坐的生活方式、不健康的饮食和不断上升的肥胖率。医用三录仪具有非侵入性监测功能，减少了去医院的频率。

整个医用三录仪产业根据技术、应用、配销通路、最终用途和地区进行分类。依技术细分，医用三录仪市场分为感测器、生物感测器和成像技术。感测器和生物感测器领域的价值到 2023 年将达到 24 亿美元，占据重要的市场份额。感测器和生物感测器擅长测量大量的生理指标，包括心率、血压、体温和血糖水平。

这种广泛的适用性意味着配备这些感测器的医疗三录仪可以满足从常规检查到慢性病监督的各种健康监测需求。从应用角度来看，医用三录仪市场分为监测与诊断。监测领域将处于领先地位，预计到2032 年收入将达到约46 亿美元。大。医疗三录仪具有监测功能，可提供有关生命体征和健康指标的即时见解，有助于有效管理这些状况。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 37亿美元
预测值 63 亿美元
复合年增长率 6.1%

此外，医用三录仪的监控功能可增强预防性医疗保健。透过促进及早发现潜在的健康问题并识别健康指标的微妙变化，及时采取干预措施成为可能。这不仅可以提高患者的治疗效果，还可以减少医疗费用，从而推动该领域的成长。 2023 年，北美医用三录仪市场估值为 17 亿美元，预计分析期间复合年增长率为 5%。

北美严格的法规，例如《药品供应链安全法》(DSCSA)，对于推广包括医疗三录仪在内的先进诊断工具至关重要。此类法规强调需要对药品进行细緻的追踪和监控，从而促进采用复杂的设备来满足法规遵循。此外，北美强大且技术先进的医疗保健基础设施，加上其对创新的承诺，为医疗三录仪等最先进解决方案的无缝整合铺平了道路。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率增加
      • 感测器技术的技术进步
      • 日益重视预防保健
    • 产业陷阱与挑战
      • 设备成本高，加上资料隐私问题
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 差距分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按技术划分，2021 - 2032 年

  • 主要趋势
  • 感测器和生物感测器
  • 影像技术

第 6 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 监控
  • 诊断

第 7 章：市场估计与预测：按配销通路，2021 - 2032 年

  • 主要趋势
  • 传统实体店
  • 电子商务

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 居家护理
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • AliveCor, Inc.
  • Avidhrt Inc
  • Basil Leaf Technologies, LLC
  • Biosense Technologies Private Limited
  • Butterfly Network, Inc.
  • Cardiomo Inc
  • ChroniSense Medical, Ltd.
  • Medtronic plc
  • MEDWAND SOLUTIONS, INC.
  • TytoCare Ltd
  • VitalConnect
简介目录
Product Code: 11230

The Global Medical Tricorder Market was valued at USD 3.7 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2032. The market's expansion is fueled by the rising prevalence of chronic diseases, advancements in sensor technologies, and an increasing focus on preventive care. The surge in chronic diseases like diabetes, cardiovascular issues, and respiratory disorders is propelling the medical tricorder market. Contributing factors include an aging population, sedentary lifestyles, unhealthy diets, and escalating obesity rates. Medical tricorders, with their non-invasive monitoring capabilities, lessen the frequency of hospital visits.

The overall medical tricorder industry is classified based on technology, application, distribution channel, end-use, and region. Segmented by technology, the medical tricorder market is divided into sensors biosensors, and imaging technology. The sensors and biosensors segment, valued at USD 2.4 billion in 2023, commanded a significant market share. Sensors and biosensors are adept at gauging a plethora of physiological metrics, including heart rate, blood pressure, body temperature, and glucose levels.

This broad applicability means medical tricorders, when outfitted with these sensors, can cater to diverse health monitoring needs, spanning from routine check-ups to chronic disease oversight. Application-wise, the medical tricorder market is divided into monitoring and diagnosis. The monitoring segment is set to lead, projecting revenues of approximately USD 4.6 billion by 2032. As chronic diseases like diabetes, hypertension, and cardiovascular issues become more prevalent, the demand for consistent and prolonged health monitoring intensifies. Medical tricorders, with their monitoring features, furnish real-time insights on vital signs and health metrics, aiding in the effective management of these conditions.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$3.7 Billion
Forecast Value$6.3 Billion
CAGR6.1%

Furthermore, the monitoring capabilities of medical tricorders bolster preventive healthcare. By facilitating early detection of potential health concerns and recognizing subtle shifts in health metrics, timely interventions become possible. This not only enhances patient outcomes but also curtails healthcare expenses, driving the segment's growth. In 2023, North America's medical tricorder market was valued at USD 1.7 billion, with projections of a 5% CAGR over the analysis period.

North America's stringent regulations, like the Drug Supply Chain Security Act (DSCSA), are pivotal in promoting advanced diagnostic tools, including medical tricorders. Such regulations emphasize the need for meticulous tracking and monitoring of pharmaceuticals, thereby fostering the adoption of sophisticated devices for regulatory compliance. Moreover, North America's robust and technologically advanced healthcare infrastructure, coupled with its commitment to innovation, paves the way for the seamless integration of state-of-the-art solutions like medical tricorders.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Technological advancements in sensor technologies
      • 3.2.1.3 Rising emphasis on preventive care
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High device cost coupled with data privacy concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Future market trends
  • 3.9 GAP analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Sensors and biosensors
  • 5.3 Imaging technology

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Monitoring
  • 6.3 Diagnosis

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Brick & mortar
  • 7.3 E-commerce

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals & clinics
  • 8.3 Homecare
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AliveCor, Inc.
  • 10.2 Avidhrt Inc
  • 10.3 Basil Leaf Technologies, LLC
  • 10.4 Biosense Technologies Private Limited
  • 10.5 Butterfly Network, Inc.
  • 10.6 Cardiomo Inc
  • 10.7 ChroniSense Medical, Ltd.
  • 10.8 Medtronic plc
  • 10.9 MEDWAND SOLUTIONS, INC.
  • 10.10 TytoCare Ltd
  • 10.11 VitalConnect